Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells.
Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J.
Pollheimer J, et al.
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):e47-55. doi: 10.1161/ATVBAHA.112.253427. Epub 2012 Nov 15.
Arterioscler Thromb Vasc Biol. 2013.
PMID: 23162017